REPL — Replimune Group Inc · $825.7M cap

Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.

Use this REPL page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the REPL quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the REPL SEC filings page. Lician reads the product cache first so this HTML stays unique to Replimune Group Inc even when a live quote feed is slow.

Replimune Group Inc latest statements (FY2026)

Latest cached year on this hub. Full REPL income, balance, and cash tables.

  • Revenue$0
  • Net Income-$313.9M
  • Total Assets$332.4M
  • Total Debt$0
  • Free Cash Flow-$284.6M

REPL recent filings